Order Article Reprints

Todorovski T, Mendonça DA, Fernandes-Siqueira LO, Cruz-Oliveira C, Guida G, Valle J, Cavaco M, Limas FIV, Neves V, Cadima-Couto Í, et al. Targeting Zika Virus with New Brain- and Placenta-Crossing Peptide–Porphyrin Conjugates. Pharmaceutics. 2022; 14(4):738. https://doi.org/10.3390/pharmaceutics14040738

Todorovski, Toni, Diogo A. Mendonça, Lorena O. Fernandes-Siqueira, Christine Cruz-Oliveira, Giuseppina Guida, Javier Valle, Marco Cavaco, Fernanda I. V. Limas, Vera Neves, Íris Cadima-Couto, and et al. 2022. "Targeting Zika Virus with New Brain- and Placenta-Crossing Peptide–Porphyrin Conjugates" Pharmaceutics 14, no. 4: 738. https://doi.org/10.3390/pharmaceutics14040738

Todorovski, T., Mendonça, D. A., Fernandes-Siqueira, L. O., Cruz-Oliveira, C., Guida, G., Valle, J., Cavaco, M., Limas, F. I. V., Neves, V., Cadima-Couto, Í., Defaus, S., Veiga, A. S., Da Poian, A. T., Castanho, M. A. R. B., & Andreu, D. (2022). Targeting Zika Virus with New Brain- and Placenta-Crossing Peptide–Porphyrin Conjugates. Pharmaceutics, 14(4), 738. https://doi.org/10.3390/pharmaceutics14040738